星空游戏网站免费进入|星空彩票电脑版

Abstract

Abstract:Long noncoding RNAs (lncRNAs) are transcribed RNA molecules greater than 200 nucleotides in length. Nowadays, lncRNAs are found to have lots of functions including regulating transcription, post-transcriptional RNA processing, translation, nuclear factor transport, gene rearrangement and chromatin modification. Abnormal expressions of lncRNAs always come along with the pathogenesis of many diseases, such as cancer, neurodegenerative disorders, and cardiovascular disease. Thus a systematic and comprehensive profiling of lncRNA will help us to have a deeper understanding of the pathogenesis of the diseases. This article will focus on the research strategies of lncRNA and the latest progress in neurodegenerative diseases, which will contribute to the establishment of the regulation network of nervous system, and provide new ideas for the prevention of neurodegenerative diseases.

Key words:long noncoding RNAs,research strategy,neurodegenerative diseases,Alzheimer&,rsquo,s disease,Parkinson&,rsquo,s disease,Huntington&,rsquo,s disease,amyotrophic lateral sclerosis

CLC Number:

R964

Zhang Zhao, Chu Shi-feng, Huang Hui-yong, Chen Nai-hong.Long Noncoding RNAs：Research Strategies and Progresses in Neurodegenerative Diseases[J]. Acta Neuropharmacologica, 2014, 4(4): 42-49.

References

[1] The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome [J]. Nature, 2012, 489 (7414):57-74.

[2] Ryan J Taft, Ken C Pang, Timothy R Mercer, et al. Non-coding RNAs: regulators of disease [J]. J Pathology, 2010, 220 (2):126-39.

[3] Carolyn J Brown, Andrea Ballabio, James L Rupert, et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome [J]. Nature, 1991, 349 (6304):38-44.

[4] Marisa S Bartolomei, Sharon Zemel, Shirley M Tilghman. Parental imprinting of the mouse H19 gene [J]. Nature, 1991, 351 (6322):153-155.

[5] Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs [J]. Nature, 2002, 420 (6915):563-573.

[6] Cristina Tufarelli, Jackie A Stanley, David Garrick, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease [J]. Nature Genetics, 2003, 34 (2):157-165.

[7] Rebecca A Chodroff, Leo Goodstadt, Tamara M Sirey, et al. Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes [J]. Genome biology, 2010, 11 (7):R72.

[8] Yamini Arthanari, Christian Heintzen, Sam Griffiths-Jones, et al. Natural antisense transcripts and long non-coding RNA in Neurospora crassa [J]. PloS One, 2014, 9 (3):e91353.

[9] Chris P Ponting, Peter L Oliver, Wolf Reik. Evolution and functions of long noncoding RNAs [J]. Cell, 2009, 136 (4):629-641.

[10] Tim R Mercer, Dagmar Wilhelm, Marcel E Dinger, et al. Expression of distinct RNAs from 3' untranslated regions [J]. Nucleic Acids Res, 2011, 39 (6):2393-2403.

[11] Tiffany Hung, Yulei Wang, Michael F Lin, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters [J]. Nature Genet, 2011, 43 (7):621-629.

[12] Ulf A Orom, Thomas Derrien, Malte Beringer, et al. Long noncoding RNAs with enhancer-like function in human cells [J]. Cell, 2010, 143 (1):46-58.

[13] Claus M Azzalin, Patrick Reichenbach, Lela Khoriauli, et al. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends [J]. Science, 2007, 318 (5851):798-801.

[14] Sara Massone, Irene Vassallo, Gloria Fiorino, et al. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease [J]. Neurobiology Dis, 2011, 41 (2):308-317.

[15] Bernard Delphine, Prasanth Kannanganattu V, Tripathi Vidisha, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression [J]. J EMBO, 2010, 29 (18):3082-3093.

[16] Ahmad M Khalil, Mitchell Guttman, Maite Huarte, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression [J]. Proc Nat Acad Sci USA, 2009, 106 (28):11667-11672.

[17] Marcel E Dinger, Paulo P Amaral, Tim R Mercer, et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation [J]. Genome Res, 2008, 18 (9):1433-1445.

[18] Miao-Chih Tsai, Ohad Manor, Wan Yue, et al. Long noncoding RNA as modular scaffold of histone modification complexes [J]. Science, 2010, 329 (5992):689-693.

[19] Chi C Gu, D C Rao, Gary Stormo, et al. Role of gene expression microarray analysis in finding complex disease genes [J]. Genetic Epidemiol, 2002, 23 (1):37-56.

[20] Tim R Mercer, Irfan A Qureshi, Solen Gokhan, et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation [J]. BMC Neurosci, 2010, 11:14.

[21] Hitzemann R, Bottomly D, Darakjian P, et al. Genes, behavior and next-generation RNA sequencing [J]. Genes Brain Behav, 2013, 12 (1):1-12.

[22] Lin Ming-yan, Erika Pedrosa, Abhishek Shah, et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders [J]. PloS One, 2011, 6 (9):e23356.

[23] Anna Esteve-Codina, Robert Kofler, Nicola Palmieri, et al. Exploring the gonad transcriptome of two extreme male pigs with RNA-seq [J]. BMC Gen, 2011, 12:552.

[24] Huang Qi-chao, Lin Biao-yang, Liu Han-qiang, et al. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma [J]. PloS One, 2011, 6 (10):e26168.

[25] Jae-Hyung Lee, Gao Chen, Peng Guang-dun, et al. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts [J]. Circulation Res, 2011, 109 (12):1332-1341.

[26] Masaaki Furuno, Ken C Pang, Noriko Ninomiya, et al. Clusters of internally primed transcripts reveal novel long noncoding RNAs [J]. PLoS Genet, 2006, 2 (4):e37.

[27] Radha Raman Pandey, Tanmoy Mondal, Faizaan Mohammad, et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation [J]. Molecular Cell, 2008, 32 (2):232-246.

[28] Ritu Jain, Tiffany Devine, Ajish D George, et al. RIP-Chip analysis: RNA-Binding Protein Immunoprecipitation-Microarray (Chip) Profiling [J]. Methods Mol Biol, 2011, 703:247-263.

[29] Zhao Jing, Toshiro K Ohsumi, Johnny T Kung, et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq [J]. Molecular Cell, 2010, 40 (6):939-953.

[30] Liao Qi, Xiao Hui-xiao, Dechao Bu, et al. ncFANs: a web server for functional annotation of long non-coding RNAs [J]. Nucleic Acids Res, 2011, 39 (Web Server issue):W118-W124.

[31] Matteo Bellucci, Federico Agostini, Marianela Masin, et al. Predicting protein associations with long noncoding RNAs [J]. Nature Methods, 2011, 8 (6):444-445.

[32] Marcel E Dinger, Ken C Pang, Tim R Mercer, et al. NRED: a database of long noncoding RNA expression [J]. Nucleic Acids Rese, 2009, 37 (Database issue):D122-D126.

[33] Mohammad Ali Faghihi, Farzaneh Modarresi, Ahmad M Khalil, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase [J]. Nature Med, 2008, 14 (7):723-730.

[34] Mohammad Ali Faghihi, Zhang Ming, Huang Jia, et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function [J]. Genome Biol, 2010, 11 (5):R56.

[35] Mus Ei, Patrick R Hof, Henri Tiedge. Dendritic BC200 RNA in aging and in Alzheimer's disease [J]. Proc Natl Acad Sci USA, 2007, 104 (25):10679-10684.

[36] Ivan Arisi, Mara D'Onofrio, Rossella Brandi, et al. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection [J]. J Alzheimer's Dis, 2011, 24 (4):721-738.

[37] Agnes Petit, Toshitaka Kawarai, Erwan Paitel, et al. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations [J]. J Biol Chem, 2005, 280 (40):34025-34032.

[38] Camilla Scheele, Natasa Petrovic, Mohammad A Faghihi, et al. The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function [J]. BMC Genomics, 2007, 8:74.

[39] Masahito Shimojo. Huntingtin regulates RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) nuclear trafficking indirectly through a complex with REST/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued [J]. J Biol Chem, 2008, 283 (50):34880-34886.

[40] Rory Johnson, Nadine Richter, Ralf Jauch, et al. Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease [J]. Physiological Genomics, 2010, 41 (3):269-274.

[41] Daniel W Chung, Dudnicki D Rudnicki, Yu Lan, et al. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression [J]. Human Mol Genet, 2011, 20 (17):3467-3477.

[42] Mauro Cozzolino, Alberto Ferri, Cristiana Valle, et al. Mitochondria and ALS: implications from novel genes and pathways [J]. Molecular and Cellular Neurosciences, 2013, 55:44-9.

[43] Edward Pokrishevsky, Leslie I Grad, Masoud Yousefi, et al. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis [J]. PloS One, 2012, 7 (4):e35050.

[44] Yoshinori Nishimoto, Shinichi Nakagawa, Tetsuro Hirose, et al. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis [J]. Molecular Brain, 2013, 6:31.

[45] George L Lee, Albert Dobi, Shiv Srivastava. Prostate cancer: diagnostic performance of the PCA3 urine test [J]. Nature Reviews Urology, 2011, 8 (3):123-124.

[46] Aya Mizrahi, Abraham Czerniak, Tally Levy, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences [J]. J Transl Med, 2009, 7:69.

Long Noncoding RNAs：Research Strategies and Progresses in Neurodegenerative Diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	LI Hui, YANG Jin-shui, XUE Qian.A Case of Huntington's Disease with Involuntary Movements of the Limbs as the First Symptom Combined with Dysarthria in the Early Stages of the Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 31-.
[2]	ZHANG Yuan-qing, LIN Yu, HUANG Li.Study on the Effects of Vitamin D on DNA Methylation in Alzheimer's Disease Cell Models[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 39-.
[3]	ZHANG Xin, YAO Si-fan, MA Meng-fan, SHEN Li-xia.Recent Progress in the Metabolomics of Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 47-.
[4]	ZHAO Yu-ting, YIN Hong-yan, GUO Chun-yan.Explore the Mechanism of Paeoniae Radix Alba Delaying Alzheimer's Disease Based on Network Pharmacology and Molecular Docking[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 1-.
[5]	YAO Si-fan, ZHANG Xin, SHEN Li-xia.Effects of Tau Protein on Mitochondrial Function in Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(4): 54-.
[6]	WANG Tian-xu, LIU Ci, CUI Yong-yuan, ZHANG Xin, WU Miao-miao, SHEN Li-xia.Explore the Mechanism of Quercetin in the Treatment of Alzheimer's Disease by Network Pharmacology and Molecular Docking[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(2): 31-.
[7]	YIN Hong-yan, YOU Si-han, GUO Chun-yan.Research Progress of Core Markers and Other Markers of Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 45-.
[8]	ZHU Jing-yi , FAN Jian-chun, YU Ai-mei.Research Status on the Neuroprotective Effect of Probucol[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 50-.
[9]	.Exploring the Effect and Mechanism of Pterostilbene on Alzheimer’s Disease Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 1-.
[10]	BAI Jing-ru, YOU Si-han, YIN Hong-yan, YANG Song-rui, GUO Chun-yan.Predicting the Target of Peach Kernel in the Treatment of Parkinson's Disease Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(3): 31-.
[11]	YU Mei-hua, ZHOU Jing, GAO Shi-jie, BAO Jin-feng.Mechanism of Sirtuins in Neurodegenerative Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(1): 35-.
[12]	GUO Bao, LIU Zi-ming, JING Yong-shuai, ZHANG Dan-shen.Correlation Between Wnt Signaling Pathway and Alzheimer's Disease and Its Targets[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(1): 56-.
[13]	SI Wen-ying, HOU Yu-qing, SUN Xiao-jing, MENG Xian-yong, DONG Xiao-hua.Gene Therapy for Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 51-56.
[14]	ZHANG Zhi-qing, ZHANG Yong-cai, LIU Lin-xuan, LI Ren-qing, LIU Ji-jia, DU Jing-kao, JIANG Bei, WEI Huiping, SU Li-ning.Bioinformatics Analysis of the Relationship between Exosomal ceRNA Regulatory Network and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 23-40.
[15]	CAI Yu-shan, ZHAO Shuai.Role of PPARβ/δ in Neurodegenerative Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 41-48.